Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

By Issue

Search Results

##search.searchResults.foundPlural##

Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

13-09-2023

https://doi.org/10.4081/dr.2023.9839

2697

PDF: 982

HTML: 32
Combined cetuximab and volumetric modulated arc-radiotherapy in advanced recurrent squamous cell carcinoma of the scalp

Uwe Wollina, Andreas Schreiber, Knut Merla, Gunter Haroske

e57

13-12-2011

https://doi.org/10.4081/dr.2011.e57

1896

PDF: 723

HTML: 1025
Efficacy of autologous serum therapy in positive and negative autologous serum skin test patients in chronic urticaria in a tertiary care centre

Raghavendra KR, Bangaru H

06-07-2022

https://doi.org/10.4081/dr.2022.9525

2139

PDF: 542

HTML: 63
Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

Paolo Dapavo, Matteo Megna, Marina Talamonti

09-08-2024

https://doi.org/10.4081/dr.2024.9999

1753

PDF: 678

HTML: 95
New and emerging therapies in cutaneous T-cell lymphoma

Gabriele Roccuzzo, Nicole Macagno, Silvia Giordano, Paolo Fava, Pietro Quaglino

02-10-2024

https://doi.org/10.4081/dr.2024.10002

1103

PDF: 595

HTML: 97
Atopic dermatitis: a brief review of recent advances in its management

Sultan Daghafak Alenazi

23-05-2023

https://doi.org/10.4081/dr.2023.9678

2402

PDF: 1409

HTML: 107
Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło

22-05-2023

https://doi.org/10.4081/dr.2023.9630

1064

PDF: 564

HTML: 75
Mortality risk factors in febrile ulceronecrotic Mucha- Habermann disease: a systematic review of therapeutic outcomes and complications

Vasiliki Tasouli-Drakou, May Nguyen, Hannah Guinn, Omron Hassan, Sneha Butala, Sheshanna Phan

21-11-2022

https://doi.org/10.4081/dr.2022.9492

1690

PDF: 679

HTML: 87
Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen

11-10-2017

https://doi.org/10.4081/dr.2017.7079

1383

PDF: 663

HTML: 142
Erythrodermic psoriasis improved by tildrakizumab

Giampaolo Trevisan, Lerica Germi, Luigi Naldi

23-11-2022

https://doi.org/10.4081/dr.2022.9448

1147

PDF: 620

HTML: 22
The efficacy of apremilast in pemphigus: a systematic review of case reports

Roudin H. Alhasawi, Esraa A. Shaheen, Noura M. Alshabanat, Reem Brashi, Walaa Abdu Ahmed, Shumukh H. Alqahtani, Ethar G. Alharbi, Mazin Aljabri

07-05-2025

https://doi.org/10.4081/dr.2025.10245

916

PDF: 403

SUPPLEMENTARY MATERIAL: 35

HTML: 9
Paradoxical reaction under dupilumab triggered by occasional ketoprofen intake

Filippo Chersi, Sanja Javor, Rosella Gallo, Elia Sala, Cesare Massone

28-02-2025

https://doi.org/10.4081/dr.2025.10214

909

PDF: 675

HTML: 9
Epidermolysis bullosa acquisita: current diagnosis and therapy

Christine R. Mehren, Robert Gniadecki

e38

28-11-2011

https://doi.org/10.4081/dr.2011.e38

1545

PDF: 837

HTML: 125
Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero

17-03-2022

https://doi.org/10.4081/dr.2022.9282

1170

PDF: 826

HTML: 41
Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza

21-11-2022

https://doi.org/10.4081/dr.2022.9447

1310

PDF: 405

HTML: 45
Rituximab for linear immunoglobulin A bullous dermatosis

Rummit Dhillon, Lily Park, Sarah Gabros, Tam Nguyen, Stanley Skopit

29-12-2022

https://doi.org/10.4081/dr.2023.9574

1361

PDF: 560

HTML: 33
CD4/CD8 double-negative mycosis fungoides: a review

Khalid Nabil Nagshabandi, Abdulrahman Shadid, Asem Shadid, Nouf K. Almuhanna

12-04-2024

https://doi.org/10.4081/dr.2024.9908

3205

PDF: 633

SUPPLEMENTARY: 113

HTML: 24
COVID-19 infection in chronic spontaneous urticaria treated with omalizumab: two case reports

Angelo Massimiliano D'Erme, Cristian Fidanzi, Marco Romanelli, Valentina Dini, Giovanni Bagnoni, Agata Janowska

24-08-2023

https://doi.org/10.4081/dr.2023.9763

792

PDF: 409

HTML: 30
Ultrasound monitoring of hidradenitis suppurativa fistulas in treatment with adalimumab

Raffaele Dante Caposiena Caro, Giulia Bazzacco, Enrico Zelin, Vanessa Mazzoletti, Nicola Di Meo, Iris Zalaudek

11-04-2025

https://doi.org/10.4081/dr.2025.10124

561

PDF: 381

HTML: 3
Metastatic basal cell carcinoma to the bone: a case of bone metastasis in uncommon sites

Olga Nigro, Claudio Chini, Ilaria Gioia Angiola Marcon, Annamaria De Giorgi, Linda Bascialla, Elisa Gallerani, Alice Giaquinto, Diego De Palma, Maurizio Lombardo

12-07-2022

https://doi.org/10.4081/dr.2022.9267

1050

PDF: 506

Supplementary Table: 231

HTML: 14
Vulvar malignant melanoma: a case report and review of its management

Maizatulernawani Hashim, Nor Hidayah Yayanto, Badrul Zaman Muda Abdullah, Fathi Ramly, Rahimah Abd Rashid, Daniel Roza Duski

04-07-2022

https://doi.org/10.4081/dr.2022.9345

1359

PDF: 432

HTML: 255
Bullous mycosis fungoides associated with an extensive ulcer and a severe leukemoid reaction

Shuei Sato, Osamu Okamoto, Michifumi Kawamoto, Masaki Oishi, Naomi Yada, Kazuhiro Kohno, Shigeo Yokoyama, Sakuhei Fujiwara

e54

02-12-2011

https://doi.org/10.4081/dr.2011.e54

1291

PDF: 677

HTML: 121
Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy

Marco May Lee, Vito Di Lernia, Francesca Peccerillo, Federico Bardazzi, Michela Tabanelli, Michela Ricci, Davide Melandri, Monica Corazza, Francesca Satolli, Andrea Conti

01-07-2025

https://doi.org/10.4081/dr.2025.10315

546

PDF: 266

HTML: 15
Adalimumab-induced facial erysipelas and its successful resolution with azithromycin in a 19-year-old female

Caterina Mariarosaria Giorgio, Anna Balato, Gaetano Licata, Giuseppe Argenziano, Vittorio Tancredi, Eugenia Veronica Di Brizzi

21-02-2025

https://doi.org/10.4081/dr.2025.10278

460

PDF: 297

HTML: 14
Certolizumab to treat hidradenitis suppurativa

Asem Shadid, Saud Alobaida, Yousef Binamer

27-10-2022

https://doi.org/10.4081/dr.2022.9566

1943

PDF: 729

HTML: 30

1 - 25 of 39 items 1 2 > >>

Search

Search Results

Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Combined cetuximab and volumetric modulated arc-radiotherapy in advanced recurrent squamous cell carcinoma of the scalp

Efficacy of autologous serum therapy in positive and negative autologous serum skin test patients in chronic urticaria in a tertiary care centre

Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

New and emerging therapies in cutaneous T-cell lymphoma

Atopic dermatitis: a brief review of recent advances in its management

Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Mortality risk factors in febrile ulceronecrotic Mucha- Habermann disease: a systematic review of therapeutic outcomes and complications

Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

Erythrodermic psoriasis improved by tildrakizumab

The efficacy of apremilast in pemphigus: a systematic review of case reports

Paradoxical reaction under dupilumab triggered by occasional ketoprofen intake

Epidermolysis bullosa acquisita: current diagnosis and therapy

Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

Rituximab for linear immunoglobulin A bullous dermatosis

CD4/CD8 double-negative mycosis fungoides: a review

COVID-19 infection in chronic spontaneous urticaria treated with omalizumab: two case reports

Ultrasound monitoring of hidradenitis suppurativa fistulas in treatment with adalimumab

Metastatic basal cell carcinoma to the bone: a case of bone metastasis in uncommon sites

Vulvar malignant melanoma: a case report and review of its management

Bullous mycosis fungoides associated with an extensive ulcer and a severe leukemoid reaction

Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy

Adalimumab-induced facial erysipelas and its successful resolution with azithromycin in a 19-year-old female

Certolizumab to treat hidradenitis suppurativa

authors

reviewers

Categories

indexing

dermatopathology